283 filings
Page 7 of 15
6-K
w9jnf4mt1c3
14 May 19
Kamada Reports Financial Results for First Quarter of 2019
7:00am
6-K
4qcw2tf ag
7 May 19
Kamada to Report First Quarter 2019 Financial Results and Host Conference Call on May 14
7:03am
6-K
ytfjz22dl933p1ahh
16 Apr 19
Kamada announces FDA acceptance of Inhaled AAT program path
7:00am
6-K
a2f1io2ne mlpj
14 Mar 19
Kamada Awarded the Israeli Outstanding Exporter Award for 2017
7:00am
6-K
q2vj y90hq66p8d6tmp
27 Feb 19
Current report (foreign)
9:04am
6-K
6ul n11j9h75kjzqkr
12 Feb 19
Kamada Reports Financial Results for Fourth Quarter and Fiscal Year 2018
12:00am
6-K
j6u qocfmopt1f
6 Feb 19
Kamada Announces Additional Interim Results from Phase 2 Proof
7:00am
6-K
5519ikzk34dypok4k
5 Feb 19
Results and Host Conference Call on February 12
7:00am
6-K
c984haxj
30 Jan 19
Kamada Appoints Senior Biopharmaceutical Executive Michal Ayalon, Ph.D., as Vice
7:00am
6-K
52lsmpvfpil47ia3v7u8
2 Jan 19
Kamada Announces Preliminary Revenue for Fourth Quarter and Full-Year 2018
7:00am
6-K
bte7otdi0b0jnvx
20 Dec 18
Current report (foreign)
8:29am
6-K
vyn2le lpwb4zwt3yyj
13 Nov 18
Kamada Reports Financial Results for Third Quarter and First Nine Months of 2018
6:14am
6-K
i5vlmy tztn3
7 Nov 18
Notice of 2018 Annual General Meeting of Shareholders
10:03am
6-K
8jaoxks qe6wbed
5 Nov 18
Financial Results and Host Conference Call on November 12
7:00am
6-K
aaeocfrflhe b1v0hg5w
22 Oct 18
Current report (foreign)
7:00am
6-K
q3vzc5m4oqn lvbf8ocs
5 Sep 18
Kamada Announces Extension of Collaboration with Massachusetts General
12:00am
6-K
clgzlgl
29 Aug 18
Kamada Provides Updated Full-Year 2018 Revenue Guidance
12:00am
6-K
pewy06f9
16 Aug 18
Current report (foreign)
7:00am
6-K
57byfj90nfczjfu2psw2
7 Aug 18
Kamada Reports Financial Results for Second Quarter and First Six Months of 2018
7:00am
6-K
n9z asohjq033dznqmmu
1 Aug 18
Results and Host Conference Call on August 7
7:02am